NYSE:IQVLife Sciences
IQVIA And Duke Partnership Highlights Obesity Focus Amid Share Price Weakness
IQVIA Holdings (NYSE:IQV) has entered a collaboration with the Duke Clinical Research Institute to advance clinical research in obesity and cardiometabolic trials.
The partnership focuses on complex clinical programs and aims to broaden access to diverse patient groups in areas of rising healthcare focus.
For investors watching IQVIA Holdings at a share price of $168.85, this new collaboration sits against a backdrop of weak recent returns. The stock has declined 6.7% over the past week,...